MKI67 and neoplasm: Immunofluorescence analysis demonstrated that PTX treatment led to a reduction in the fluorescence intensity of Ki-67 in tumor tissue, while LC3B, VPS34, and caspese-3-positive cells accumulated in tumor tissue.